These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 561984)

  • 1. Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes.
    Ladisich W
    Psychoneuroendocrinology; 1977; 2(3):257-66. PubMed ID: 561984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate.
    de Greef WJ; Dullaart J; Zeilmaker GH
    J Endocrinol; 1976 Sep; 70(3):465-71. PubMed ID: 978105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.
    Yanai R; Nagasawa H
    Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary effects of progestational agents in emphysematous rats.
    Ino T; Aviado DM
    Chest; 1971 Jun; 59(6):659-66. PubMed ID: 5087936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
    Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
    Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of depo-medroxyprogesterone acetate on serum progesterone levels when administered on various cycle days.
    Siriwongse T; Snidvongs W; Tantayaporn P; Leepipatpaiboon S
    Contraception; 1982 Nov; 26(5):487-93. PubMed ID: 6218964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of LH release with synthetic LH-RH (author's transl)].
    Koyama T
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):881-97. PubMed ID: 828583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma norepinephrine during the rat estrous cycle and after progesterone treatment to the ovariectomized estrogen-primed rat.
    Nagle CA; Rosner JM
    Neuroendocrinology; 1976; 22(1):89-96. PubMed ID: 1035969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-induced sexual receptivity and localization of 3H-estradiol in brains of female mice: effects of 5 alpha-reduced androgens, progestins and cyproterone acetate.
    Luttge WG; Jasper TW; Gray HE; Sheets CS
    Pharmacol Biochem Behav; 1977 May; 6(5):521-8. PubMed ID: 896889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
    Frank DW; Kirton KT; Murchison TE; Quinlan WJ; Coleman ME; Gilbertson TJ; Feenstra ES; Kimball FA
    Fertil Steril; 1979 Mar; 31(3):340-6. PubMed ID: 437169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
    Parkington HC; Lipton A
    J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric complications of progesterone and oral contraceptives.
    Glick ID; Bennett SE
    J Clin Psychopharmacol; 1981 Nov; 1(6):350-67. PubMed ID: 7037875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of seizures with medroxyprogesterone acetate: preliminary report.
    Mattson RH; Cramer JA; Caldwell BV; Siconolfi BC
    Neurology; 1984 Sep; 34(9):1255-8. PubMed ID: 6540415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone acetate (DMPA).
    Aedo AR; Landgren BM; Diczfalusy E
    Contraception; 1981 Aug; 24(2):117-35. PubMed ID: 6457729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle.
    Nygren KG; Johansson ED; Wide L
    Contraception; 1974 Mar; 9(3):249-56. PubMed ID: 4442274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.